enVVeno Medical Corp is a pioneering medical device company focused on revolutionizing vascular access solutions for dialysis patients through its proprietary biocompatible technology. Addressing critical unmet needs within the dialysis sector, enVVeno enhances both the safety and efficacy of vascular procedures, positioning itself for significant growth in the expanding vascular interventions market. With a commitment to advanced engineering and stringent regulatory compliance, the company is strategically aligned with the evolving healthcare landscape and is focused on improving patient outcomes in a vital area of medical care.
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | $-20.76M |
| Operating Margin | 0.00% |
| Return on Equity | -56.20% |
| Return on Assets | -35.10% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $41.36 |
| Price-to-Book | 0.25 |
| Price-to-Sales (TTM) | 216.91 |
| EV/Revenue | 274.86 |
| EV/EBITDA | -0.87 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | 655,520 |
| Float | 473,920 |
| % Insiders | 14.52% |
| % Institutions | 31.52% |